Loading...
•
Jun 30, 2022
Definitive Healthcare Q2 2022 Earnings Report
Revenue increased, driven by enterprise client base growth and strategic product releases.
Key Takeaways
Definitive Healthcare reported strong second-quarter results with a 37% year-over-year revenue increase to $54.5 million. The company also demonstrated the leverage of its business model with adjusted EBITDA.
Revenue was $54.5 million, an increase of 37% from Q2 2021.
Net loss was ($9.6) million, compared to ($15.0) million in Q2 2021.
Adjusted EBITDA was $16.3 million, or 30% of revenue, compared to $14.4 million, or 36% of revenue in Q2 2021.
Unlevered free cash flow was $19.1 million, or 35% of revenue.
Forward Guidance
The Company is issuing the following financial guidance based on information as of August 4, 2022.
Positive Outlook
- Third Quarter 2022 Revenue is expected to be in the range of $56.0 – $57.0 million, a 31% increase year over year.
- Third Quarter 2022 Adjusted Operating Income is expected to be in the range of $14.5– $15.5 million.
- Third Quarter 2022 Adjusted EBITDA is expected to be in the range of $15.5– $16.5 million.
- Third Quarter 2022 Adjusted Net Income is expected to be $6.5 – $7.5 million.
- Third Quarter 2022 Adjusted Net Income Per Diluted Share is expected to be $0.03 – $0.05 on approximately 155.4 million weighted-average shares outstanding.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...